ELIZABETH SCHEIDLER: Open Payments
NPI 1467776716 · KUTTAWA, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$547 in 25 payments from 8 companies in 2025. Trend: 2023 $578 · 2024 $2,379 · 2025 $547
Food & beverage: $547
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $107 |
| Novo Nordisk Inc | 2 | $73 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| AstraZeneca Pharmaceuticals LP | 1 | $53 |
| Vanda Pharmaceuticals Inc. | 2 | $42 |
| PFIZER INC. | 2 | $38 |
| ABBVIE INC. | 2 | $29 |
Products named: Auvelity, CAPLYTA, REXULTI, AIRSUPRA, Wegovy, NURTEC ODT, FANAPT, HETLIOZ.
Industry payments across KY — which companies pay providers there.
